Next-generation sequencing (NGS) has transformed the field of oncology. Early successes in identifying and targeting oncogenic drivers of solid tumors…

Wednesday, March 25, hear from Dr. Anthony M Magliocco, CEO and Founder of Protean BioDiagnostics, as he discusses the application…

Investigators in the UK are using QIAGEN Clinical Insight (QCI) to identify clinically actionable mutations from blood-based sequencing results On…

Sean Scott, QIAGEN’s Chief Business Officer and Vice President of Business Development for Clinical Genomics and Bioinformatics, discusses the N-of-One…

With great networking opportunities, exciting panel discussions, and a packed exhibit hall, Precision Medicine World Conference 2019 was the place…

Introducing a novel myeloid gene panel for the GeneReader NGS System with integrated variant analysis, interpretation and reporting from QIAGEN…

As the number of genomes sequenced each day continues to skyrocket and healthcare professionals increasingly rely on genetic information to…

Health care providers need access to up-to-date and clinically-actionable clinical decision support tools in order to adopt precision medicine. But, how…

This week we’ll be attending the Healthcare Information and Management Systems Society (HIMSS) mega-conference in Las Vegas, and we hope…

Future of Genomics The concept of precision medicine is beautifully simple: deliver the right treatment, every time, to the right…

Accelerating the deployment of precision medicine capabilities How a leading academic hospital is analyzing complex clinical data and uncovering new…

Looking ahead: the future bioinformatics of genetic testing and precision medicine The next big medical frontier is on the horizon….